Gaudium IVF and Women Health Limited (GAUDIUMIVF) Q2 FY27 Financial Results: PAT ₹1.8 & Revenue ₹19.4(2 announcements)

Gaudium IVF reported Q1FY27 revenue of ₹19.4 Cr, up 9.13% YoY, driven by mature hub growth and international patient traction. EBITDA fell 52.96% YoY to ₹2.4 Cr due to expansion costs, while PAT declined 42.27% YoY to ₹1.8 Cr. The company launched its first new IVF hub in South Extension, New Delhi, and approved a ₹15 Cr women's hospital in Lucknow. Board highlighted AI-powered embryology tools (SiD/ERICA) improving clinical outcomes to 62% first-attempt success. Expansion plans include 10 hubs in FY27, with debt-light balance sheet supporting responsible growth in India's underpenetrated fertility market.

Gaudium IVF and Women Health Limited announced on August 13, 2026, that CAx SKGN& Associates LLP was appointed as the new independent auditor following a board meeting that approved unaudited Q1 FY2026 results showing total income of ₹2,050.02 lakhs and profit after tax of [amount context mismatch] lakhs. The filing confirms no material misstatements and limited assurance under SEBI Regulation 33, while also detailing IPO fund utilization and upcoming AGM on September 28, 2026.